Cardano (CRYPTO: ADA) founder Charles Hoskinson slammed Ripple (CRYPTO: XRP) CEO Brad Garlinghouse for backing the Senate’s Clarity Act draft, warning the bill hands too much power to the SEC and lock[...]
Read more
Top News
Intercontinental Exchange, Apollo Global Management and a Tech Stock on CNBC’s ‘Final Trades’
On CNBC’s “Halftime Report Final Trades,” Malcolm Ethridge, managing partner at Capital Area Planning Group, said ServiceNow, Inc. (NYSE:NOW) is starting to separate itself from the rest of the[...]
Read more
Car-Mart Shrinks Footprint To Drive Efficiency, Protect Profits
America’s Car-Mart, Inc. (“Car-Mart”) (NASDAQ:CRMT) said Tuesday it has completed the second phase of its SG&A cost-cutting plan, consolidating 13 underperforming locations into higher-performing[...]
Read more
How a Weak Dollar Just Punched a Hole in Birkenstock’s Sales
Birkenstock Holding plc (NYSE:BIRK) stock fell Monday after the company issued a preliminary update on its fiscal first-quarter performance. Details Birkenstock said it expects fiscal first-quarter 20[...]
Read more
Velo3D Wins $32.6 Million Defense Contract, Stock Soars
Velo3D, Inc. (NASDAQ:VELO) stock jumped on Monday after the advanced manufacturing specialist secured a federal contract designed to break production bottlenecks in a critical weapons program. The com[...]
Read more
Senate Confirms Trump’s Crypto-Friendly Nominees
The U.S. Senate has confirmed the appointments of two of President Donald Trump‘s nominees, who are expected to play vital roles in regulating the crypto sector. Senate Confirms Crypto-Focused Regulat[...]
Read more
Ken Griffin Blames Tariffs For ‘Sticky’ Inflation: Trump Policy as Future Relief
Citadel CEO Ken Griffin stated that while there is “no doubt” that President Donald Trump inherited an economy grappling with inflation, some of his own policies have been inflationary. Griffin Says D[...]
Read moreJohnson & Johnson Wins FDA Nod for First Precision Combo for Mutated Prostate Cancer
On Friday, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson’s (NYSE:JNJ) supplemental New Drug Application (sNDA) for Akeega (niraparib and abiraterone acetate) plus pr[...]
Read more
Plug Power Landed NASA. But The Debt Fix Matters More
Plug Power Inc (NASDAQ:PLUG) shares are trading higher Tuesday morning as investors rally behind a series of strategic wins that strengthen the hydrogen leader’s global and financial positioning. Here[...]
Read more